Estrumate® 250 µg/ml Solution for Injection
Estrumate contains cloprostenol, a synthetic PGF2 alpha analogue.
Presentation
A clear, colourless solution
Active ingredients
Contains Cloprostenol Sodium 0.263 mg/ml (equivalent to 0.250 mg/ml Cloprostenol)
Target species
Cattle and horses
Indications for use
Cattle
- Suboestrus or non-detected oestrus
- Induction of parturition
- Termination of normal pregnancy
- Termination of abnormal pregnancy
- Mummified foetus
- Hydrops of the foetal membranes
- Chronic endometritis (pyometra)
- Ovarian luteal cysts
- Controlled breeding
Horses
- Induction of luteolysis following early foetal death and resorption
- Termination of persistent dioestrus
- Termination of pseudopregnancy
- Treatment of lactation anoestrus
- Establishing oestrous cycles in barren/maiden mares
- As an aid to stud management
Withdrawal periods
Cattle
- Milk 0 hours, meat 1 day
Horses
- Not to be used in horses intended for human consumption.
- Treated horses may never be slaughtered for human consumption.
- The horse must have been declared as not intended for human consumption under national horse passport legislation.
Packaging
Supplied as 10 ml and 20 ml Type I colourless glass vials sealed with synthetic ethyl tetrafluoroethylene (ETFE) coated bromobutyl rubber stoppers secured with aluminium collars with flip-seal caps. Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: March 2023